Use of sclerosing substances in the treatment of oral hemangiomas - case report
DOI:
https://doi.org/10.33448/rsd-v11i3.26647Keywords:
Sclerotherapy; Hemangioma; Treatment.Abstract
Currently, hemangioma is determined by the proliferation of blood vessels, a benign vascular neoplasm. It can appear as a kind of bubble, with a color that varies from red to purple. It has a high incidence in the head, neck and oral cavity region, constantly affecting the tongue, cheek mucosa and lips. Patients report painful symptoms in some cases, have difficulty in speech and chewing and aesthetic impairment. The knowledge of this neoplasm is of great importance to the dentist to perform the proper management. Among the therapeutic means, sclerotherapy is one of the least invasive choices, it has been applied more frequently, as satisfactory clinical and aesthetic results are presented. Therefore, this work will report a clinical case of a patient with Hemangioma, in which the sclerotherapy protocol with 0.05g / ml monoethanolamine oleate will be performed as an alternative treatment, achieving complete lesion involution, and without recurrence after 12 months.
References
Assis, G. M., et al. (2009). Hemangioma de língua: relato de caso. Rev Cir Traumatol Buco-Maxilo-fac. (v.9):59 – 66.
Àville, E. D., et al. (2010). Hemangioma cavernoso labial em uma criança pequena. Ir. Dent J. 4(3):147-50.
Açikgöz, A., et al. (2000). Rare benign tumours of oral cavity—capillary haemangioma of palatal mucosa: a case report. Int J Paediatr Dent.
Boraks, S. (2011). Medicina bucal tratamento clínico-cirúrgico das doenças bucomaxilofaciais. Artes Médicas. 20-30.
Das, B. K., et al. (2008). Treatment of venous malformations with ethanolamine ole ate. Asian J Surg. 3(2):45-58.
Enjolras, O., et al. (1996). Anomalias cutâneas vasculares em crianças: malformações e hemangiomas. Pediatr Surg Int. 5(6): 37-49.
Freitas, C. B., et al. (2021). Diagnóstico e tratamento do hemangioma em lábio inferior: Relato de caso. Research, Society and Development, 10(1), e25910111765.
Gómez, Z. (1984). Hemangiomas. Tratamiento. Resultados en 15 casos tratados. Acta Odontol Venez.
Hassani, A., et al. (2006). Management of mandibular vascular malformation with sclerotherapy. Report of two cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 4(7): 45-79.
Lloret, P. (2004). Tratamiento médico de los hemangiomas. An Sist Sanit Navar. 6(7): 23-25.
Mariano, F. V., et al. (2011). Sclerotherapy followed by surgery for the treatment of oral hemangioma: a report of two cases. Gen Dent. 8(2): 135-137.
McHeik, J. N., et al. (2005). Surgical treatment of haemangioma in infants. Br J Plast Surg.
Neville, B., et al. (2009). Patologia oral e maxilofacial. (3a ed.).
Oksiuta, M., et al. (2016). Tratamento de hemangiomas em rápida proliferação em recém-nascidos com propranolol e revisão da literatura. J Matern Fetal Neonatal Med. 4(3):14-17.
Pereira, A. S., et al. (2018). Metodologia da pesquisa científica. UFSM.https://repositorio.ufsm.br/bitstream/handle/1/1582 4/Lic_Computacao_Metodologia-Pesquisa-Cientifica.pdf?sequence=1.
Rocha, L.B., et al. (2000). Hemangioma da cavidade bucal. Rev Gaúcha Odontol.
Sapp, J., et al. (2012). Patologia bucomaxilofacial contemporânea. São Paulo. (7) 89-95.
Selim, H., et al. (2007). Use of sclerosing agent in the management of oral and perioral hemangiomas: review and case reports. Med Sci Monit.
SEO, J., et al. (2009). Escleroterapia de hemangioma labial. Rev. Odonto. 7(8) 56-76.
Wang, L., et al. (1998). Tratamento de Hemangioma Bucal com Agente Esclerosante. Robrac.
Zheng, J.W., et al. (2013). Um guia prático para o tratamento de hemangiomas infantis da cabeça e pescoço. Int J Clin Exp Med. 5(6) 55-60.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Ranelle Souza Bernardino; Radamés Bezerra Melo ; Eduardo Brito de Lima; Raissa Pinheiro Moraes; Rayane Gurgel Monteiro; Heitor Casimiro Linhares
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
